Stephen J Tulipano - Net Worth and Insider Trading
Stephen J Tulipano Net Worth
The estimated net worth of Stephen J Tulipano is at least $298,426 dollars as of 2024-11-13. Stephen J Tulipano is the CFO of Stoke Therapeutics Inc and owns about 20,746 shares of Stoke Therapeutics Inc (STOK) stock worth over $282,561. Stephen J Tulipano is also the CFO of Aldeyra Therapeutics Inc and owns about 3,333 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $15,865. Details can be seen in Stephen J Tulipano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen J Tulipano has not made any transactions after 2024-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen J Tulipano
Stephen J Tulipano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen J Tulipano owns 2 companies in total, including Stoke Therapeutics Inc (STOK) , and Aldeyra Therapeutics Inc (ALDX) .
Click here to see the complete history of Stephen J Tulipano’s form 4 insider trades.
Insider Ownership Summary of Stephen J Tulipano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2024-03-19 | CFO |
| ALDX | Aldeyra Therapeutics Inc | 2017-02-17 | Chief Financial Officer |
Stephen J Tulipano Latest Holdings Summary
Stephen J Tulipano currently owns a total of 2 stocks. Among these stocks, Stephen J Tulipano owns 20,746 shares of Stoke Therapeutics Inc (STOK) as of March 19, 2024, with a value of $282,561 and a weighting of 94.68%. Stephen J Tulipano also owns 3,333 shares of Aldeyra Therapeutics Inc (ALDX) as of February 17, 2017, with a value of $15,865 and a weighting of 5.32%.
Latest Holdings of Stephen J Tulipano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2024-03-19 | 20,746 | 13.62 | 282,561 |
| ALDX | Aldeyra Therapeutics Inc | 2017-02-17 | 3,333 | 4.76 | 15,865 |
Holding Weightings of Stephen J Tulipano
Stephen J Tulipano Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen J Tulipano has made a total of 3 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Stoke Therapeutics Inc is the sale of 4,116 shares on March 19, 2024, which brought Stephen J Tulipano around $25,108.
According to the SEC Form 4 filings, Stephen J Tulipano has made a total of 0 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 3,333 shares on February 17, 2017, which cost Stephen J Tulipano around $14,999.
Insider Trading History of Stephen J Tulipano
- 1
Stephen J Tulipano Trading Performance
GuruFocus tracks the stock performance after each of Stephen J Tulipano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen J Tulipano is -12.75%. GuruFocus also compares Stephen J Tulipano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen J Tulipano within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen J Tulipano's insider trading performs compared to the benchmark.
Performance of Stephen J Tulipano
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.92 | | | | | |
| Relative Return to S&P 500(%) | 2.77 | | | | | |
Stephen J Tulipano Ownership Network
Ownership Network List of Stephen J Tulipano
Ownership Network Relation of Stephen J Tulipano
Stephen J Tulipano Owned Company Details
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Stephen J Tulipano is the CFO of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include Chief Medical Officer Barry Ticho , 10 percent owner Skorpios Trust , and COO & CBO Huw M. Nash .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Stephen J Tulipano made 1 insider transaction in Stoke Therapeutics Inc (STOK) with a net sale of 4,116. Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 134,116 shares made by Barry Ticho , a net sale of 18,022 shares made by Jonathan Allan , and a net sale of 56,616 shares made by Huw M. Nash .
In summary, during the past 3 months, insiders sold 1,967,500 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 1,967,500 shares. During the past 18 months, 5,803,870 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,803,870 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
Stephen J Tulipano Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen J Tulipano. You might contact Stephen J Tulipano via mailing address: C/o Javelin Pharmaceuticals, Inc., 125 Cambridge Park Drive, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
